We are focused on pulmonary disease and development of unique patented technology for inhalation therapy. Control of a pressurized carrier gas and prescribed pharmaceutical is input and controllable on a per patient basis. The carrier gas of Heliox, air, oxygen, or a combination of gases each have specific dynamics and therefore the potential to target pharmaceutical delivery to specific regions of the respiratory system, allowing for reduced dosage and reduced side effect profiles. Disposable single use cartridges are integral in the design for quality assurance of each prescribed dose over a series of doses on a per patient basis.
WHY HELIOX?
During severe acute asthma exacerbations, it has been found that albuterol nebulized with Heliox leads to a more significant improvement in spirometry when compared with albuterol nebulized with oxygen because the low-density gas improves albuterol deposition in the distal airways.
Inhalation of Heliox results in significantly lower turbulence, particularly in the more distal portions of the lung. The decreased turbulence results in an increased flow by up to 50% during Heliox inhalation.
Evidence continues to evolve that heliox can effectively reduce airway resistance and work of breathing in patients with severe airway obstruction and can improve delivery of aerosol by reducing turbulence and aerosol particle impact en route to the lungs.
BENEFITS OF HELIOX
Increases Drug Deposition in Distal Parts of the Lungs
Reduces Work of Breathing
Reduces Respiratory Rate and Auto-Positive-End Expiratory-Pressure (Auto-Peep)
Increases Expiratory Flow
Reduces the Peak Pressure Needed to Maintain Flow
Increases CO2 Elimination and Improves Gas Exchange
Nontoxic, Noncarcinogenic, No Lasting Effects
